WO2023220502 - COMPOSITIONS AND METHODS FOR RECOMBINANT PARVOVIRUS PRODUCTION
National phase entry:
Publication Number
WO/2023/220502
Publication Date
16.11.2023
International Application No.
PCT/US2023/064152
International Filing Date
10.03.2023
Title **
[English]
COMPOSITIONS AND METHODS FOR RECOMBINANT PARVOVIRUS PRODUCTION
[French]
COMPOSITIONS ET PROCÉDÉS POUR LA PRODUCTION DE PARVOVIRUS RECOMBINÉ
Applicants **
AAVNERGENE INC.
Inventors
WANG, Qizhao
YU, Daozhan
LIU, Yu
CHEN, Cuiping
YANG, Rongze
Priority Data
63/341,201
12.05.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2800 | |
| EPO | Filing, Examination, Granting | 16322 | |
| Japan | Filing, Examination, Granting | 2593 | |
| South Korea | Filing, Examination, Granting | 2769 | |
| USA | Filing, Examination, Granting | 7340 |
Total:
31,824
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Expression constructs and methods for recombinant parvovirus production are disclosed. In some embodiments, the expression construct encodes (1) adenovirus E4 and E2a proteins, (2) parvovirus proteins necessary for the production of the recombinant parvovirus, and (3) a recombinant parvovirus genome, thus allowing production of the recombinant parvovirus by transfecting a host cell with a single expression construct.[French]
La présente invention concerne des constructions d'expression et des procédés pour la production de parvovirus recombiné. Selon certains modes de réalisation, la construction d'expression code (1) les protéines E4 et E2a de l'adénovirus, (2) les protéines du parvovirus nécessaires à la production du parvovirus recombiné, et (3) un génome de parvovirus recombiné, permettant ainsi la production du parvovirus recombiné par transfection d'une cellule hôte avec une seule construction d'expression.